BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qiang W, Cai W, Yang Q, Yang L, Dai Y, Zhao Z, Yin J, Li Y, Li Q, Wang Y, Weng X, Zhang D, Chen Y, Zhu X. Artemisinin B Improves Learning and Memory Impairment in AD Dementia Mice by Suppressing Neuroinflammation. Neuroscience 2018;395:1-12. [DOI: 10.1016/j.neuroscience.2018.10.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Huang W, Wang N, Ouyang D, Xiao L, Zhang S, Ou X, He T, Yu R, Song L. Development of Arteannuin B Sustained-Release Microspheres for Anti-Tumor Therapy by Integrated Experimental and Molecular Modeling Approaches. Pharmaceutics 2021;13:1236. [PMID: 34452197 DOI: 10.3390/pharmaceutics13081236] [Reference Citation Analysis]
2 Olajide OA, Sarker SD. Alzheimer's disease: natural products as inhibitors of neuroinflammation. Inflammopharmacology 2020;28:1439-55. [PMID: 32930914 DOI: 10.1007/s10787-020-00751-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
3 Elisei LMS, Moraes TR, Malta IH, Charlie-silva I, Sousa IMO, Veras FP, Foglio MA, Fraceto LF, Galdino G. Antinociception induced by artemisinin nanocapsule in a model of postoperative pain via spinal TLR4 inhibition. Inflammopharmacol 2020;28:1537-51. [DOI: 10.1007/s10787-020-00756-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Cucos CA, Dobre M, Dragnea EM, Manda G, Milanesi E. Increased MYD88 blood transcript in a mouse model of Alzheimer’s disease. BMC Neurosci 2022;23. [DOI: 10.1186/s12868-022-00699-8] [Reference Citation Analysis]
5 Fu C, Yu P, Wang M, Qiu F. Phytochemical analysis and geographic assessment of flavonoids, coumarins and sesquiterpenes in Artemisia annua L. based on HPLC-DAD quantification and LC-ESI-QTOF-MS/MS confirmation. Food Chemistry 2020;312:126070. [DOI: 10.1016/j.foodchem.2019.126070] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
6 Lu BW, Baum L, So KF, Chiu K, Xie LK. More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration. Neural Regen Res 2019;14:1494-8. [PMID: 31089038 DOI: 10.4103/1673-5374.255960] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
7 Efferth T, Oesch F. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases. Med Res Rev 2021. [PMID: 34288018 DOI: 10.1002/med.21842] [Reference Citation Analysis]
8 Kiss E, Kins S, Zöller Y, Schilling S, Gorgas K, Groß D, Schlicksupp A, Rosner R, Kirsch J, Kuhse J. Artesunate restores the levels of inhibitory synapse proteins and reduces amyloid-β and C-terminal fragments (CTFs) of the amyloid precursor protein in an AD-mouse model. Mol Cell Neurosci 2021;113:103624. [PMID: 33933588 DOI: 10.1016/j.mcn.2021.103624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kshirsagar SG, Rao RV. Antiviral and Immunomodulation Effects of Artemisia. Medicina (Kaunas) 2021;57:217. [PMID: 33673527 DOI: 10.3390/medicina57030217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhang T, Zhang X, Lin C, Wu S, Wang F, Wang H, Wang Y, Peng Y, Hutchinson MR, Li H, Wang X. Artemisinin inhibits TLR4 signaling by targeting co-receptor MD2 in microglial BV-2 cells and prevents lipopolysaccharide-induced blood-brain barrier leakage in mice. J Neurochem 2021;157:611-23. [PMID: 33453127 DOI: 10.1111/jnc.15302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhong Q, Zou Y, Liu H, Chen T, Zheng F, Huang Y, Chen C, Zhang Z. Toll-like receptor 4 deficiency ameliorates β2-microglobulin induced age-related cognition decline due to neuroinflammation in mice. Mol Brain 2020;13:20. [PMID: 32059688 DOI: 10.1186/s13041-020-0559-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Lin SP, Wei JX, Hu JS, Bu JY, Zhu LD, Li Q, Liao HJ, Lin PY, Ye S, Chen SQ, Chen XH. Artemisinin improves neurocognitive deficits associated with sepsis by activating the AMPK axis in microglia. Acta Pharmacol Sin 2021;42:1069-79. [PMID: 33758353 DOI: 10.1038/s41401-021-00634-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kiss E, Kins S, Gorgas K, Orlik M, Fischer C, Endres K, Schlicksupp A, Kirsch J, Kuhse J. Artemisinin-treatment in pre-symptomatic APP-PS1 mice increases gephyrin phosphorylation at Ser270: a modification regulating postsynaptic GABAAR density. Biol Chem 2021. [PMID: 33878252 DOI: 10.1515/hsz-2021-0153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Chen X, Drew J, Berney W, Lei W. Neuroprotective Natural Products for Alzheimer's Disease. Cells 2021;10:1309. [PMID: 34070275 DOI: 10.3390/cells10061309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]